Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCP1105 in Combined Hyperlipidemia With High CHD Risk
NCT02551172Phase 3Unknown
- Sponsor
- Hanmi Pharmaceutical
- Start
- Oct 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HCP1105 in hyperlipidemia, sponsored by Hanmi Pharmaceutical. Status: unknown.
02
Drugs
HCP1105
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02551172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02551172.